Endocrine Metabolic & Immune Disorders-Drug Targets

Journal Metrics
(Based on the publications from the last 4 years)
(from 2020-11-01 to roughly 2024-11-01)
Number of papers889
H4-Index17
TQCC4
Average citations3.127
Median citations1
Impact Factor2.000 (based on Web of Science 2023)

(API-Link)

Categories & Ranks
Metric:
(Based on the publications from the last 4 years)
Most cited by this journal
(Based on citations to the other journals in the most recent 30 papers in this journal, at least if metadata about citations were available; last updated 2024-10-22)
Impactful Papers
(Based on publications since 2023; last updated 2024-08-30)
Altmetric Attention Score: 45
Correlation Between Vitamin B12 Deficiency and Autoimmune Thyroid Diseases
Endocrine Metabolic & Immune Disorders-Drug Targets 2023-01-29
Altmetric Attention Score: 38
Healthy Diets and Lifestyles in the World: Mediterranean and Blue Zone People Live Longer. Special Focus on Gut Microbiota and Some Food Com
Endocrine Metabolic & Immune Disorders-Drug Targets 2024-08-02
Altmetric Attention Score: 15
A Case of Intractable Hypophosphatemia in a Patient with Guillain-Barré Syndrome and Encephalitis after SARS-CoV-2 Infection
Endocrine Metabolic & Immune Disorders-Drug Targets 2024-02-09
Altmetric Attention Score: 10
Anti-viral Effects of Pavetta indica Methanolic Extract and Acyclovir on Behavioral and Biochemical Parameters in Streptozotocin-induced Alz
Endocrine Metabolic & Immune Disorders-Drug Targets 2024-05-02
Altmetric Attention Score: 4
Novel DNMT3B Mutation in a Patient with Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome and a Bronchopulmonar
Endocrine Metabolic & Immune Disorders-Drug Targets 2023-03-29
Ad
0.0058391094207764